Background: Chronic alcohol consumption leads to increased fracture risk and an elevated risk of osteoporosis by decreasing bone accrual through increasing osteoclast activity and decreasing osteoblast activity. We have shown that this mechanism involves the generation of reactive oxygen species (ROS) produced by NADPH oxidases. It was hypothesized that different dietary antioxidants, N-acetyl cysteine (NAC; 1.2 mg/kg/d), and a-tocopherol (Vit.E; 60 mg/kg/d) would be able to attenuate the NADPH oxidase-mediated ROS effects on bone due to chronic alcohol intake.
C HRONIC ALCOHOL CONSUMPTION is a wellknown risk factor for osteoporosis and low bone mass (Berg et al., 2008; Chakkalakal, 2005; Sampson, 2002) . Bone remodeling is controlled by a delicate equilibrium between osteoclast activity, the removal of old bone, and osteoblast activity, the formation of new bone (Sims and Vrahnas, 2014; Zaidi, 2007) . Multiple investigators have shown that alcohol affect both aspects of this balance, inhibiting osteoblastogenesis (Chen et al., 2010; Turner et al., 2010) and stimulating osteoclastogenesis (Dai et al., 2000; Mercer et al., 2014; Wezeman et al., 2000) . Alcohol also affects the lineage commitment of bone marrow mesenchymal stromal cells, altering their progression toward osteoblasts and redirecting them to become adipocytes (Chen et al., 2010) . Chronic alcohol consumption impacts the bone in other ways as well. Alcohol reduces the number of proliferating chondrocytes in the tibial growth plate of rats fed ethanol (EtOH) via total enteral nutrition . Chondrocytes secrete the cartilaginous matrix essential for the process of endochondral ossification. The ordered progression of chondrocyte differentiation and columnar arrangement of the chondrocytes proceeds from the articular ends to the shaft of long bones. The continued proliferation of less mature chondrocytes at the extremities, followed by their differentiation into hypertrophic chondrocytes, and finally their replacement by trabecular bone near the center result in bone longitudinal growth (St Jacques et al., 1999) . Additionally, EtOH has been shown to increase bone cell senescence (Chen et al., 2009 ) and apoptosis (Mercer et al., 2012) . Extensive oxidative stress causes damage to DNA, proteins, and lipids (Balaban et al., 2007; Droge, 2002) and may play a critical role in alcohol-induced osteopenia Ronis et al., 2011) .
Oxidative stress plays a key role in several pathologies such as cancer (Filaire et al., 2013; Hardbower et al., 2013; Paschos et al., 2013) , cardiovascular disease (Donato et al., 2015) , and aging (Kong et al., 2014) . Dietary antioxidant supplementation has garnered attention over the last decade as means of disease prevention. Dietary supplements with antioxidant properties have been shown to exhibit profound effects on bone. Soy protein isolate , blueberries , and genistein have all been reported to have bone anabolic effects in vivo.
Other dietary antioxidants have been tested in attempts to identify substances that are protective against reactive oxygen species (ROS)-related bone loss. For example, N-acetyl cysteine (NAC) is a small molecule amino acid derivative and glutathione precursor. It also has antioxidant properties and is currently in clinical use as an antidote for acetaminophen overdose. Alone, dietary NAC supplementation was shown to increase bone volume and bone mineral density (BMD) as well as decrease osteoclast differentiation in mice (Cao and Picklo, 2014) . In a study to determine the effectiveness of NAC as a postfracture osteogenic supplement molecule, a collagenous sponge enhanced with NAC was compared to the sponge itself in the ability to help repair a bone defect. The NAC supplemented sponge supported bone healing significantly better than the sponge alone (Yamada et al., 2013) . In addition, NAC has previously been shown to block osteopenia in rats fed EtOH intragastrically via total enteral nutrition and to prevent alcoholrelated deficient fracture healing in mice Roper et al., 2016) .
Vitamin E, a-tocopherol (Vit.E), is a polyisoprenoid derivative with antioxidant activities which is a true free radical scavenger. However, the true effect of Vit.E on bone is uncertain. A review of studies on Vit.E in fracture repair suggested that Vit.E may impact bone remodeling and healing due to its antioxidant properties, but cited the need for more data to be collected (Borhanuddin et al., 2012) . In a study using mice genetically unable to import Vit.E, mice displayed decreased bone mass due to increased osteoclast fusion. Upon feeding of Vit.E to these mice, a normal bone mass phenotype was restored and osteoclast fusion remained elevated (Fujita et al., 2012) . Despite these findings, in a study using ovariectomy-induced bone loss, Vit.E at 60 mg/kg per day and pure tocotrienol at the same dose were completely protective (Muhammad et al., 2012) .
Given that alcohol-related bone loss involves ROSinduced signaling pathways, in this study 2 different dietary antioxidants with different mechanisms of action were tested as protective agents against alcohol-induced pathology in the skeletons of female mice.
MATERIALS AND METHODS

Animals and Experimental Design
All experimental procedures involving animals were approved by the Institutional Animal Care and Use Committee at the University of Arkansas for Medical Sciences. Mice were housed in an Association Assessment and Accreditation of Laboratory Animal Care approved animal facility. Eighty, 6-week-old WT female mice (Jackson Laboratories, Bar Harbor, ME) were randomly assigned to 6 weight-matched groups: a 28% EtOH liquid diet (n = 10), a corresponding pair-fed (PF) control (n = 10), a 28% EtOH liquid diet plus NAC (1.2 mg/kg/d) (n = 10), a corresponding PF control plus NAC (PF + NAC) (n = 10), a 28% EtOH liquid diet plus Vit.E (60 mg/kg/d) (n = 10), and a corresponding PF control plus Vit.E (PF + Vit.E) (n = 10). All groups had access to water ad libitum. EtOH was added to the Lieber-DeCarli liquid diet (35% of energy from fat, 18% from protein, 47% from carbohydrates) by slowly substituting carbohydrate calories for EtOH calories (#710260; Dyets, Inc., Bethlehem, PA) in a stepwise manner until 28% total calories were reached, which constitutes final EtOH concentration of 4.9% (v/v), respectively, and maintained until sacrifice (40 days; Mercer et al., 2012) . Mice being fed a Lieber-DeCarli-control diet (Dyets#710027) were isocalorically matched to their corresponding EtOH group based on the diet consumptions of the previous day (PF). We have previously published data showing that under these conditions, mice reach blood EtOH concentrations of 150 to 200 mg/dl, a value close to twice the current legal limit of 80 mg/dl for driving while impaired and easily attainable in chronic alcoholics (Mercer et al., 2012) . The dose of NAC chosen was that we have previously reported to be protective against alcoholic osteopenia in rats . The dose of Vit.E chosen was based on the dose reported by Muhammad and colleagues (2012) to protect against ovariectomy-induced bone loss in female rats. At sacrifice, trunk blood was collected and femurs were frozen at À80°C for mRNA extraction. Right tibial bones were fixed in formalin for peripheral quantitative computerized tomography (pQCT) and microcomputed tomography (MicroCT) analyses, and left tibial bones were fixed in EtOH for immunohistochemistry.
Peripheral Quantitative Computerized Tomography Analyses
Ex vivo cortical BMD, cortical bone area, and trabecular BMD were measured in the tibias collected from all PF and EtOH-treated mouse groups using a STRATEC XCT Research SA + pQCT (Orthometrix, White Plains, NY) in a blinded fashion as previously described (Shankar et al., 2008a,b) . Proximal tibias were analyzed using the manufacturer's software version 5.40. Three contiguous sections, 1 mm apart, distal to the proximal end were measured for cortical and trabecular BMD and cortical area with a spatial resolution of 100 lm. Thresholds of 207 and 285 mg/cm 3 were used to distinguish trabecular and cortical bone, respectively. Average values for all slices were calculated for statistical analysis.
Microcomputed tomography Analyses
All MicroCT analyses were consistent with current guidelines for the assessment of bone microstructure in rodents (Bouxsein et al., 2010) . Formalin-fixed tibias were imaged using a MicroCT 40 (Scanco Medical AG, Bassersdorf, Switzerland) using a 12 lm isotropic voxel size in all dimensions. The region of interest selected for analysis comprised 240 transverse CT slices representing the entire medullary volume extending 1.24 mm distal to the end of the primary spongiosa with a border lying 100 lm from the cortex. ]) were calculated using previously published methods (Suva et al., 2008) .
Real-Time Reverse Transcriptase Polymerase Chain Reaction Analyses
Total RNA was isolated by crushing whole femur shaft in RLT buffer (Qiagen, Germantown, MD) and using the RNeasy RNA isolation kit (Qiagen) as per manufacturer's instructions. All RNA were reverse transcribed using IScript cDNA synthesis (Bio-Rad Laboratories, Hercules, CA) according to manufacturer's instructions, and subsequent real-time PCR analysis was performed using SYBR green and an ABI 7500 sequence detection system (Applied Biosystems, Foster City, CA). Gene expression from the entire femoral shaft was quantified using the deltaC T method relative to 18s and then the appropriate control. Comparisons of raw C T values did not differ between groups, indicating that 18s was an appropriate normalizer. Gene-specific primers were as follows: 18s-Fwd GAG GCC CTTG TAA TTG GAA TGA G, Rev CGC TAT TGG AGG TGG AAT TAC C; aP2-Fwd CAA AAT GTG TGA TGC CTT TGT G, Rev CTC TTC CTT TGG CTC ATG CC; p21 -Fwd TGG GAT GCA CTG GGT GTT CT, Rev CCT TCC TCA CCT GTG TCG TCT T.
Estimation of Fat Volume/Tissue Volume
To estimate the relative volume occupied by fat cells in the tibia, decalcified paraffin-embedded histologic sections (5 lm) were stained with hematoxylin and eosin. Fat area measurements were performed in the secondary spongiosa $ 1 mm below the lowest portion of the growth plate using OsteoMeasure software (OsteoMetrics, Decatur, GA). Measurements were performed throughout the entire width of the bone (until the cortical surface), covering area $ 4 to 5 mm below the growth plate.
Number of Proliferating Chondrocytes in the Tibial Growth Plate and Assessment of Bone Length
The number of proliferating chondrocytes in the growth plate of control, EtOH-fed, and antioxidant-fed animals was enumerated from H&E-stained histologic sections. Average numbers of cells in a 4009 magnification were counted in 3 separate fields from 3 mice per group using an EVOS-FL microscope (Advanced Microscopy Group, Bothell, WA) and imaging software (Olympus, Melville, NY). Proliferating chondrocytes were identified by their semiflattened appearance, deep nuclear staining, and location within the growth plate. The distance from the proximal tibial head to the tibia-fibula junction was assessed using digital calipers (Thermo Scientific, Rockford, IL), and measurements were made on all formalin-fixed tibias from all feeding groups.
Nitrotyrosine Staining
For immunohistochemical analysis, antigen retrieval was performed by heating sections in 10 mM sodium citrate buffer (pH 6.0) for 20 minutes. Endogenous peroxidase was quenched by incubating the sections with Peroxidase Suppressor (Thermo Scientific) for 15 minutes at room temperature (RT). The slides were blocked with Non-Serum Protein Block (Dako, Carpinteria, CA) for 20 minutes at RT. Primary antibodies were prepared in antibody diluent solution (0.5% nonfat dry milk and 1% bovine serum albumin in Trisbuffered saline) and incubated overnight at 4°C. The concentration of primary antibody and dilution for Anti-Nitrotyrosine was 1:6,000 (Millipore, Temecula, CA). The specificity of the nitrotyrosine antibody binding was confirmed by blocking the antibody with 3-nitrotyrosine (10 mM). Immunoreactivity was detected by Dako Envision + System-HRP (Dako).
Statistical Analysis
Data were expressed as means AE SEM. Two-way analysis of variance (ANOVA) followed by Student-Newman-Keuls post hoc analysis was used to compare groups. Values were considered statistically significant at p < 0.05 and are reported as such.
RESULTS
Study Observations
There was no observed effect of liquid diet feeding with respect to weight gain, and the final weights from each group were as follows: control PF 22.7 g (SEM 0.6), EtOH 22.3 g (SEM 0.8), NAC 22.5 g (SEM 0.5), NAC/EtOH 22.8 g (SEM 0.3), Vit.E 23.3 g (SEM 0.4), and Vit.E/EtOH 21.9 g (SEM 0.6). Feeding of EtOH resulted in a blood EtOH concentration of 189 mg/dl (SEM 28). In groups fed NAC with EtOH, blood EtOH concentration was 182 mg/dl (SEM 28), and in the group fed Vit.E with EtOH, blood EtOH was 164 mg/dl (SEM 36). There were no significant differences between blood EtOH levels in mice fed an antioxidant with EtOH and mice fed EtOH alone.
Dietary Antioxidants Protect Against Alcohol-Induced Trabecular Bone Loss, but not Cortical Bone Loss in Female Mice
pQCT analysis of fixed tibias showed that chronic alcohol consumption (EtOH) significantly reduced trabecular bone density and cortical bone density compared to PF controls (Table 1) . Neither antioxidant, NAC, nor Vit.E, was able to protect against alcohol-induced reduction of cortical bone density. However, Vit.E was partially protective against decreased cortical area due to alcohol (Table 1) . Mice in the PF + NAC group exhibited significantly lower trabecular bone density compared to mice receiving the PF diet alone. However, pQCT showed that there were no significant differences between trabecular bone densities in either of the EtOH + antioxidant groups compared to their respective PF + antioxidant controls.
a-Tocopherol and N-Acetyl Cysteine Feeding Resulted in Different Levels of Protection Against Alcohol-Induced Trabecular Bone Loss
MicroCT analysis of trabecular bone performed on fixed tibias revealed that EtOH significantly reduced BV/TV and Tb.N and increased trabecular separation (Tb.Sp.) compared to tibias from PF controls. There was no effect on trabecular thickness observed regardless of antioxidant supplementation, with or without alcohol (Figs 1 and 2A,B,D) . NAC completely protected against the EtOH-induced decrease in BV/TV% and increase in Tb.Sp. NAC was partially protective against reduced Tb.N due to EtOH feeding (Fig. 1A,B,  D) . Vit.E completely protected against the decrease in BV/ TV due to chronic EtOH and partially protected against the EtOH-associated increase in Tb.Sp. However, Vit.E was unable to protect against the EtOH-induced decrease in Tb.N ( Fig. 2A,B,D) .
N-Acetyl Cysteine Completely Blocks the Increase in Reactive Oxygen Species in Bone Due to Chronic Alcohol Consumption
Previous studies from our laboratory have shown that the effects of chronic EtOH on bone can be attributed to increased oxidative stress (Chen et al., 2008 (Chen et al., , 2010 Mercer et al., 2014) . It was shown in vitro, through dichlorodihydrofluorescein fluorescence, that the addition of EtOH to osteoblast cultures caused an increase in oxidative stress, and this could be blocked by NAC or estradiol (Chen et al., 2008) . In this study, we go further and demonstrate using nitrotyrosine staining, that chronic EtOH feeding increases ROS-associated protein adducts and, therefore, that EtOH does indeed cause excess production of ROS in bone in vivo.
Tibias from EtOH-fed mice show a dramatic increase in nitrotyrosine staining compared to PF controls (Fig. 3) . No staining was observed in tibia sections from mice fed NAC. Similarly, in sections from mice fed EtOH + NAC, there was no visible nitrotyrosine staining indicating complete protection. Interestingly, in sections from mice fed Vit.E alone and sections from EtOH + Vit.E fed mice, nitrotyrosine staining was visible (Fig. 3) . Data are expressed as the mean with SEM in parentheses. Statistical significance was determined by 2-way ANOVA followed by Student-NewmanKeuls post hoc analysis. Values with different superscripts letter are statistically different from each other (p < 0.05). 
N-Acetyl Cysteine Protects Against the Alcohol-Induced Increase in Adipocyte Protein 2 Expression and the Increase in Number of Bone Marrow Adipocytes
Adipocyte protein 2 (aP2) is a commonly used marker for fully differentiated adipocytes, and aP2 has been used previously to measure marrow adiposity associated with alcohol consumption (Chen et al., 2008) . Indeed, EtOH feeding significantly increased the expression of aP2 compared to PFcontrol mice. Feeding NAC completely blocked the increase in aP2 associated with EtOH (Fig. 4A) . Vit.E was also protective against the increase in aP2 expression due to EtOH (Fig. 4C) . Decalcified sections from tibias were stained with H&E to assess marrow adiposity. Tibias from mice chronically fed EtOH exhibited a significantly higher number of adipocytes per square millimeter compared to PF-control mice. Mice fed EtOH + NAC were protected against the increase in adipocyte number (Fig. 4B) . Vit.E supplementation significantly increased the number of marrow adipocytes compared to controls, but there was no difference in adipocyte number between tibias from EtOH + Vit.E and Vit.E alone (Fig. 4D ).
Both N-Acetyl Cysteine Feeding and a-Tocopherol Feeding Prevent Alcohol-Induced Reduction in Proliferating Chondrocytes
In tibia sections stained with H&E, proliferating chondrocytes in the growth plate were identified and counted. Previously, we have observed that rats fed EtOH via total enteral nutrition have significantly reduced numbers of proliferating chondrocytes in the growth plate compared to controls . We observed a similar phenomenon in mice fed EtOH using a Lieber-DeCarli liquid diet. NAC feeding and Vit.E feeding were both able to block the alcohol-induced decrease in the number of proliferating chondrocytes within the growth plate (Fig. 5) . Chronic alcohol feeding resulted in a significant 1 mm reduction in the distance from the proximal tibia head to the tibia-fibula junction. Mice fed NAC exhibited a significantly reduced distance compared to control PF mice, but not to the degree of EtOH-fed controls. There was no difference in tibia distances between mice fed EtOH + NAC and NAC alone (Table 2 ). Mice fed Vit.E also displayed a significantly lesser distance from the proximal tibia head to the tibia-fibula junction, but again not to the extent of EtOH-fed control mice. Tibia distances were not statistically different between mice fed EtOH + Vit.E and Vit.E alone (Table 2) .
N-Acetyl Cysteine and a-Tocopherol Protect Against AlcoholAssociated Increase in p21 Expression
Aside from affecting osteoblastogenesis and osteoclastogenesis, it has been shown previously that alcohol stimulates bone cell senescence (Chen et al., 2009) . mRNA expression of the senescence marker p21 was measured, and there was a significant increase in femurs from mice fed EtOH. Both NAC and Vit.E feeding protected against the increase in p21 expression due to chronic alcohol consumption (Fig. 6 ).
DISCUSSION
It is well established that EtOH-induced skeletal pathology is driven by ROS signaling pathways that reduce bone accrual by altering bone remodeling homeostasis. Dietary antioxidants have proven useful in preventing disease by reducing ROS signaling. In the present study, 2 dietary antioxidants, NAC and Vit.E, were shown to partially prevent EtOH-induced osteopenia by reducing ROS and its subsequent signaling effects. Female mice received EtOH liquid diets with or without antioxidant supplementation for 8 weeks. As expected, chronic EtOH treatment induced a clear increase in ROS as measured by nitrotyrosine staining and resulted in decreased cortical and trabecular BMD (Table 1) . Both NAC and Vit.E were able to protect against trabecular bone loss due to EtOH but not against cortical bone loss. NAC has been shown to function by multiple mechanisms of action, with free radical scavenging capabilities as well as being able to increase intracellular glutathione, and it also is able to act as a reducing agent through a thiolsulfide exchange activity (Kim et al., 2001; Zafarullah et al., 2003) . Vit.E was shown to have the highest antioxidant efficiency of all the tocopherols, and its primary function was to scavenge peroxyl radicals to protect poly unsaturated fatty acids and lipid membranes (Traber and Atkinson, 2007) . These data suggest that the protective effects of NAC on EtOH-induced osteopenia are not unique or related solely to effects on GSH levels, but are more generally related to its antioxidant and free radical scavenging properties.
The broad effects of EtOH on bone turnover have been well documented (Chakkalakal, 2005; Ronis et al., 2011; Turner, 2000) . EtOH also has several indirect effects on bone, including inhibition of growth hormone secretion (Badger et al., 1993) , reductions in fibroblast growth factors (Zhao et al., 2015) , and suppression of the calcium-vitamin D axis (Mercer et al., 2012; Shankar et al., 2008a) . In addition, EtOH has been shown to have direct apoptotic effects on bone cells and activate cellular senescence pathways (Chen et al., 2009; Mercer et al., 2012) . In a rat model of TEN, the feeding of chronic EtOH resulted in decreased BMD, trabecular bone volume, and osteoblast number while Fig. 4 . Assessment of bone marrow adiposity by measuring (A and C) aP2 mRNA expression from femurs of PF-control mice, EtOH-fed mice, and NAC-fed, NAC + EtOH-fed, Vit.E-fed, and Vit.E + EtOH-fed mice. From H&E-stained sections of tibias, the number of marrow adipocytes per square millimeter was counted (B and D). Data are expressed as the mean AE SEM. Statistical significance was determined by 2-way ANOVA followed by StudentNewman-Keuls post hoc analysis. Values with different letter subscripts are statistically different from each other (p < 0.05). increasing trabecular separation, eroded surface, and osteoclast number . These effects were completely ameliorated when rats were fed either the antioxidant NAC or the pan-NADPH oxidase inhibitor diphenyleneiodonium, which suggested a role for NADPH oxidases in the pathology of alcohol in bone.
Previous studies using a rat total enteral nutrition model have demonstrated that oxidative stress caused by EtOH impacts the lineage commitment of mesenchymal stromal cells. Specifically, EtOH was shown to inhibit b-catenin translocation to the nucleus, thereby blocking Wnt/b-catenin signaling reducing osteoblastogenesis and promoting adipogenesis. These EtOH effects were blocked by treatment with NAC (Chen et al., 2010 Shankar et al., 2008b) . Marrow adipocytes and bone marrow adiposity are becoming increasingly recognized as important regulators of bone remodeling (Kawai et al., 2012; Scheller et al., 2014) . There is now compelling evidence that bone marrow adipose tissue acts as an endocrine organ; specifically, the inhibition of marrow adipose tissue accumulation elevates levels of adiponectin (Cawthorn et al., 2014) . In this study, both NAC and Vit.E were able to block the EtOH-induced increase in aP2 mRNA expression in femur and that NAC protected against the increase in the number of marrow adipocytes per square millimeter due to chronic EtOH consumption. Vit.E feeding alone increased the number of marrow adipocytes compared to PF controls, and no difference was observed between Vit.E and EtOH + Vit.E groups. It is possible that at the dose used in these studies, Vit.E is having pro-oxidant effects by itself. EtOH-induced ROS clearly impacts mesenchymal stromal cell differentiation and thus the bone marrow cellular milieu. It is likely that chronic EtOH consumption is also impacting the endocrine activity of bone marrow adipose tissue. Further studies are needed to determine the impact of EtOH on marrow adipose tissue's endocrine control of adiponectin.
Chondrocytes are another bone cell phenotype derived from mesenchymal stromal cells (Johnstone et al., 1998) which are essential for normal endochondral bone formation and long bone growth. Both chondrogenesis and chondrocyte hypertrophy are activated by canonical Wnt/b-catenin signaling specifically through Sox9 (Yano et al., 2005) . Among the many negative effects of chronic EtOH consumption on bone, EtOH has been shown to reduce both the number of proliferating chondrocytes in the growth plate of rats and block Wnt/b-catenin signaling in mesenchymal stromal cells by inhibiting the translocation of b-catenin to the nucleus (Chen et al., 2010) . Previously, ROS has been shown to impact chondrocyte differentiation in vitro through the stimulation of MAPK/ERK-activating kinase pathway and via p38 (Morita et al., 2007) . We have previously demonstrated that EtOH causes sustained ERK expression in osteoblasts which drives RANKL induction (Chen et al., 2006) . In this study, we show for the first time that both antioxidants, NAC and Vit.E, were able to block the inhibitory effect of EtOH on chondrogenesis, suggesting that EtOH-induced ROS inhibits chondrogenic signaling in mice in vivo.
Chondrocyte proliferation and differentiation is critical for bone lengthening (Kronenberg, 2003) . As expected, EtOH-fed mice that had less proliferating chondrocytes had significantly shorter bones. The measurement of bone length in this study, from the proximal tibia head to the tibia-fibula junction, was chosen to eliminate any potential error in the total tibia length which could occur during dissection of the distal tibia. Measuring from the proximal tibia head to the tibia-fibula junction provided a distance between 2 Data are expressed as the mean followed by the SEM. Statistical significance was determined by 2-way ANOVA followed by StudentNewman-Keuls post hoc analysis. Values with different superscripts letter are statistically different from each other (p < 0.05). Fig. 6 . Assessment of bone cell senescence by measuring (A and B) p21 mRNA expression from femurs of PF-control mice, EtOH-fed mice, and NAC-fed, NAC + EtOH-fed, Vit.E-fed, and Vit.E + EtOH-fed mice. Data are expressed as the mean AE SEM. unbiased fixed points. While NAC and Vit.E were able to protect against the alcohol-induced decrease in proliferating chondrocytes, mice fed the antioxidants with EtOH had longer bones compared to EtOH-fed groups, but that they were still significantly shorter than bones from PF-control mice. Elevated ROS in growth plates of mice has previously been shown to disrupt the columnar proliferation of chondrocytes and their hypertrophic differentiation (Morita et al., 2007) . Our data suggest that in addition to ROSmediated effects on chondrogenesis, indirect, non-ROS mediated the effects of chronic alcohol consumption on growth hormone/IGF-1 signaling (Badger et al., 1993; Srivastava et al., 2002; Wang et al., 2004) ; the calcium/vitamin D axis (Mercer et al., 2012; Shankar et al., 2008a) or effects on regulation of local growth factors in the growth plate such as Indian hedgehog, fibroblast growth factors, or bone morphogenetic proteins (Wei et al., 2016) may also significantly impact bone lengthening.
EtOH has been implicated in stimulating bone cell senescence by activating p53 and p21 (Chen et al., 2009) . We observed that NAC and Vit.E completely protected against the increase in p21 mRNA expression associated with EtOH in vivo. There are previous reports of ROS being important for regulating tumor suppressor genes and senescence (Colavitti and Finkel, 2005; Rufini et al., 2013) . We have previously reported that estradiol treatment is able to suppress EtOH-induced p21 expression and b-galactosidase activity and suggested that ROS is involved in the negative cross-talk of estradiol on EtOH signaling in bone cells in vitro (Chen et al., 2009 ). These findings confirm that alcohol-induced ROS is involved in the stimulation of bone cell senescence.
Mice that received EtOH + NAC or EtOH + Vit.E in this study were protected against trabecular bone loss, but not cortical bone loss due to EtOH. This suggests compartment-specific effects of EtOH on bone in the mouse. It is possible that previously reported endocrine disruption produced by chronic EtOH consumption such as reductions in plasma estradiol or calcium and vitamin D3 (Shankar et al., , 2008a is responsible for ROS-independent cortical bone loss. Alternatively, previously reported apoptotic effects of EtOH on osteocytes may impact the cortical bone more than the trabecular bone in this species (Mercer et al., 2012) . The findings of this article also contribute evidence to support the idea that the trabecular and cortical compartments of bone are regulated differently. Recent reports suggest that the cortical compartment is regulated through estrogen receptor signaling, specifically estrogen receptor alpha-activating factor 2 (Borjesson et al., 2011 (Borjesson et al., , 2013 Khosla et al., 2011) . Moreover, a novel member of the Wnt family, Wnt16, has recently been shown to have compartment-specific effects on bone mass (MoverareSkrtic et al., 2015) . We and others have previously reported that chronic EtOH treatment results in extensive disruption of the Wnt-b-catenin system which is critical for osteoblastogenesis, including reduced expression of a number of Wnts including Wnt3a (Callaci et al., 2010; Chen et al., 2010; Lauing et al., 2012) . However, the effects of EtOH on expression of Wnt16 in bone are currently unknown.
In conclusion, the findings presented here demonstrate that chronic EtOH is causing elevated ROS production in the bone which contributes to its negative effects. EtOHinduced ROS not only impacts bone formation and resorption, but as we demonstrate here also impacts bone cell senescence and, report for the first time in the mouse, also impacts chondrocyte proliferation and subsequent long bone length. It is clear from these findings that ROS signaling is involved in many different processes in bone, including regulation of trabecular bone turnover, and the disruption of those signals by EtOH is highly detrimental to the skeleton.
Collectively, these data demonstrate that concurrent feeding of both water-and lipid-soluble dietary antioxidants NAC and Vit.E is able to block specific effects, but not all of the effects of alcohol consumption on the skeleton of growing female mice.
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